Feature Articles
-
2024 LIMS Trends
3/15/2024
The laboratory information management system (LIMS) landscape in 2024 is a dynamic one, driven by accelerating advancements in technology and evolving industry needs. This article shares the four key trends.
-
A New Model Approach To Drug Shortage Prevention
3/15/2024
The ISPE's Drug Shortages Prevention Model revamps its predecessor, the more prescriptive Drug Shortages Prevention Plan, with a focus on 12 key performance areas.
-
Can Today’s ELNs Support Tomorrow’s Labs?
3/14/2024
The global electronic laboratory notebook (ELN) market is growing, and so is the demand for hybrid solutions that provide a solid foundation for analytics.
-
Analyzing Serum-Free Media For Cell Therapy Applications
3/14/2024
Identifying critical factors and their concentrations with an eye towards designing an ideally formulated, defined serum-free medium should be carried out using rational and systematic approaches.
-
Metabolite Analysis In Cell Therapy Development
3/14/2024
Understand the importance of metabolic analysis in cell therapy, optimizing cell culture media formulations, and enhancing the effectiveness of CAR T-cell therapy and stem cell transplantation.
-
The Importance Of Specificity In Preclinical Drug Development Models
3/13/2024
It is crucial for models to not only detect toxic drugs but also to avoid erroneously identifying safe drugs as harmful. Learn about the importance of specificity in the early stages of drug development.
-
Unraveling The Complexities Of Cancer Through Human-Relevant Models
3/13/2024
The current paradigm in preclinical testing for cancer therapeutics is proving inadequate. Learn about Organ-on-a-Chip technology and how it is improving 3D cancer modeling.
-
Selecting The Right pDNA Supplier: 10 Key Factors To Consider
3/13/2024
Selecting the right pDNA supplier is a critical decision that can significantly impact the success of your project or research. Consider these 10 key factors to help you make an informed choice.
-
Doubling Down On Biopharma’s Growing Skills Drought
3/13/2024
The biopharmaceutical industry is building manufacturing capacity at breakneck speed. According to PhRMA, there are 1,580-and-counting biopharma manufacturing facilities in the U.S. alone. Problem is, we're way short on filling those facilities with skilled labor. NIIMBL wants to change that. Here's how, and a great opportunity for big pharma, biotech sponsors, CDMOs, academics, and more to help.
-
A CDMO’s Checklist For Prospective Clients: Part 3
3/13/2024
In the last entry of our client checklist series, we delve into crucial aspects such as project management, decision-making, MSA negotiations, and building trust in CDMO-client partnerships.